Zuoqing granules attenuate ulcerative colitis via macrophage polarization modulation: involvement of the PPAR-γ/NF-κB/STAT1 signaling axis
Frontiers in Pharmacology · 11.08.2025 · 16
DOI: 10.3389/fphar.2025.1646545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.08.2025. Verfasst von Heng Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Second Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although our prior clinical study demonstrated the efficacy of Zuoqing granules (ZQGs) in treating ulcerative colitis (UC), the underlying immunomodulatory mechanisms remained unclear. This study systematically investigated ZQG’s therapeutic effects through macrophage polarization modulation and related signaling pathways using both in vivo and in vitro models.
Methods
In vivo , dextran sulfate sodium (DSS)-induced UC rats were divided into normal control, DSS model, and ZQG treatment groups (high/medium/low doses). Colon tissues were analyzed using histopathology [hematoxylin and eosin (HE) staining], macrophage phenotyping (CD86 + /CD206 + immunofluorescence and flow cytometry), signaling pathway assessment (PPAR-γ, NF-κB p65, p-NF-κB p65, and STAT1 through Western blot/qPCR), and cytokine profiling (TNF-α, IL-6, IL-10, IL-1β, and IL-4 using ELISA). In vitro , lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages were treated with ZQG-conditioned medium and a PPAR-γ antagonist (GW9662) to validate direct effects.
Results
ZQG treatment dose-dependently (1) ameliorated colonic mucosal damage, reducing histological scores by 52% compared to that in the model group, (2) modulated macrophage polarization by increasing the M2 phenotype (CD206 + cells, 3.25-fold increase) while decreasing M1 macrophages (CD86 + cells, 70% reduction), (3) upregulated PPAR-γ expression (2.0-fold increase) while suppressing NF-κB activation (43% decrease in p-NF-κB) and STAT1 signaling (48% and 40% reductions in protein and mRNA levels, respectively), and (4) rebalanced inflammatory cytokines, with 55%–62% reductions in TNF-α, IL-6, and IL-1β and 185%–210% increases in IL-10 and IL-4. In vitro studies further confirmed that ZQG directly shifted macrophage polarization via PPAR-γ, inhibiting M1 polarization (an effect abolished by GW9662).
Conclusion
ZQG ameliorates UC by modulating macrophage plasticity through the PPAR-γ/NF-κB/STAT1 axis, a mechanism validated in vitro as PPAR-γ-dependent. These findings elucidate its clinical efficacy and support its use as a multi-target UC therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anorectal Surgery, Second Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China.
- Department of Anorectal Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Zitieren
APA
Deng, H., Li, M., Fang, X., Tang, K., Xu, S., Ding, R., & Li, Z. (2025). Zuoqing granules attenuate ulcerative colitis via macrophage polarization modulation: involvement of the PPAR-γ/NF-κB/STAT1 signaling axis. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1646545
Vancouver
Deng H, Li M, Fang X, Tang K, Xu S, Ding R, et al. Zuoqing granules attenuate ulcerative colitis via macrophage polarization modulation: involvement of the PPAR-γ/NF-κB/STAT1 signaling axis. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1646545
BibTeX
@article{Deng2025,
author = {Deng, Heng and Li, Ming and Fang, Xiaoli and Tang, Kun and Xu, Shuqing and Ding, Rui and Li, Zilong},
title = {Zuoqing granules attenuate ulcerative colitis via macrophage polarization modulation: involvement of the PPAR-γ/NF-κB/STAT1 signaling axis},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1646545}
}
EUVIMED